Longevity & BioregulatorsUpdated July 2, 2026 · Educational reference

What Is Chonluten? Dosage, Half-Life & How to Track It

Also known as: Glu-Asp-Gly · EDG Peptide · Khavinson Bioregulator

ClassBronchopulmonary tripeptide bioregulator (Glu-Asp-Gly)
Typical dose250 mcg→4,000 mcg daily (8–16-wk titration)
Half-lifeNot established in humans (short tripeptide; expected minutes-scale clearance)
Typical routeSubcutaneous, once daily, 8–16 week titration
Used forLung & bronchopulmonary support
Quick answer

Chonluten is a synthetic tripeptide — Glu-Asp-Gly — from Vladimir Khavinson’s bioregulator research, studied in cell models for effects on bronchopulmonary (lung) tissue and inflammatory signaling. Protocols titrate gradually from 250 mcg up to 4,000 mcg subcutaneously once daily over eight to sixteen weeks. Human dosing data is limited; this page is educational only.

What Chonluten is and how it works

Chonluten is a third member of the Khavinson tripeptide bioregulator family alongside Pinealon and Cartalax — in this case Glu-Asp-Gly, studied specifically for effects on bronchopulmonary tissue. Preclinical cell-model research has looked at its influence on monocyte and macrophage inflammatory pathways, the immune cells most involved in lung tissue’s response to irritation and damage.

Like the other short peptides in this family, it isn’t orally stable, so subcutaneous injection is the route used in the studies and protocols that exist. The evidence is preclinical — in-vitro and cell-model work rather than human clinical trials — so treat the mechanism as a plausible research direction, not an established respiratory treatment.

Typical dosing & reconstitution

Chonluten is reconstituted with bacteriostatic water — a 20 mg vial in 3 mL gives roughly 6.67 mg/mL, where one insulin-syringe unit is about 66.7 mcg. Of the bioregulators in this batch, Chonluten has the widest published titration range and the longest runway to the top dose.

WeeksDaily doseUnits (U-100) ≈
Weeks 1–2250 mcg3.75 units (0.0375 mL)
Weeks 5–61,000 mcg15 units (0.15 mL)
Weeks 9–102,000 mcg30 units (0.30 mL)
Weeks 13–164,000 mcg60 units (0.60 mL)

The full published schedule steps up every one to two weeks; for the smallest early doses (under 10 units), a 30- or 50-unit insulin syringe reads more precisely than a standard U-100.

Half-life & why the titration runs so long

No human half-life has been published for Chonluten. As a tripeptide, the working assumption — consistent with the rest of this bioregulator family — is fast clearance via normal peptidase breakdown, on the order of minutes rather than hours.

The unusually long titration (up to 16 weeks) isn’t about half-life at all; it reflects how wide the published dose range is — a 16-fold increase from starting to top dose — so the schedule spreads that climb across small, gradual steps rather than jumping to an effective dose quickly.

What to track & considerations

Reported tolerability is generally favorable, with injection-site reaction as the main practical issue reported. Given the limited independent human data, working through the full titration slowly — rather than skipping steps — is the more conservative approach.

Worth tracking: which week (and therefore which dose) you’re on, since the range moves by a factor of 16 across the protocol, plus whatever respiratory or wellbeing marker motivated starting it.

How to track Chonluten in Stackeddd

Log each dose against the titration week — with a 16-fold range from start to finish, knowing your current dose at a glance beats recalculating from a table. Reconstitution math is set once per vial and carries through the whole multi-month protocol.

Model it yourself · free, no account

Reconstitution Calculator

Model it yourself: enter your vial size and BAC water and the Peptides tab returns concentration and exact syringe units for any dose in the titration — the same math built into the Stackeddd app.

Related compounds

Related reading: Peptide reconstitution math: how much BAC water to add

Frequently asked questions

What is Chonluten used for?

Chonluten is a Khavinson tripeptide bioregulator studied in preclinical cell models for effects on bronchopulmonary tissue and inflammatory (monocyte/macrophage) pathways. Human clinical trial data is limited.

What is the half-life of Chonluten?

No formal human half-life is published. As a tripeptide it’s expected to clear quickly (likely minutes) via normal peptidase breakdown, consistent with once-daily dosing.

How long is a Chonluten titration?

Published schedules run 8 to 16 weeks, starting around 250 mcg daily and stepping up roughly every one to two weeks to a top dose of about 4,000 mcg.

How do you reconstitute Chonluten?

Add 3 mL of bacteriostatic water to a 20 mg vial for about 6.67 mg/mL — a 1,000 mcg dose is then about 15 units on a U-100 insulin syringe.

This is educational information, not medical advice. Doses and protocols above reflect published references and community practice — protocol decisions belong with your prescribing physician. Generic names used throughout. How this reference is built & how the AI is tested →

STACKEDDD

Track it instead of guessing.

Doses, reconstitution, bloodwork, and an AI coach grounded in your own data — free to start, on the App Store and Google Play.

App StoreGoogle Play

← Back to the compound library